203 related articles for article (PubMed ID: 31039836)
1. Spatiotemporal distribution and determinants of measles incidence during a large outbreak, Italy, September 2016 to July 2018.
Andrianou XD; Del Manso M; Bella A; Vescio MF; Baggieri M; Rota MC; Pezzotti P; Filia A
Euro Surveill; 2019 Apr; 24(17):. PubMed ID: 31039836
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania.
Lazar M; Stănescu A; Penedos AR; Pistol A
Euro Surveill; 2019 Jul; 24(29):. PubMed ID: 31339098
[TBL] [Abstract][Full Text] [Related]
3. Surveillance and vaccination coverage of measles and rubella in Northern Italy.
Amendola A; Bubba L; Piralla A; Binda S; Zanetti A; Pariani E; Ranghiero A; Premoli M; Pellegrinelli L; Coppola L; Gramegna M; Baldanti F; Zanetti A
Hum Vaccin Immunother; 2015; 11(1):206-13. PubMed ID: 25483537
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of measles, mumps and rubella in Italy.
Gabutti G; Rota MC; Salmaso S; Bruzzone BM; Bella A; Crovari P;
Epidemiol Infect; 2002 Dec; 129(3):543-50. PubMed ID: 12558337
[TBL] [Abstract][Full Text] [Related]
5. Resurgence risk for measles, mumps and rubella in France in 2018 and 2020.
Béraud G; Abrams S; Beutels P; Dervaux B; Hens N
Euro Surveill; 2018 Jun; 23(25):. PubMed ID: 29945697
[TBL] [Abstract][Full Text] [Related]
6. Measles, mumps, rubella prevention: how can we do better?
Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
[TBL] [Abstract][Full Text] [Related]
7. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
Wang Z; Yan R; He H; Li Q; Chen G; Yang S; Chen E
PLoS One; 2014; 9(2):e89361. PubMed ID: 24586717
[TBL] [Abstract][Full Text] [Related]
8. Pediatric sentinel surveillance of vaccine-preventable diseases in Italy.
Ciofi Degli Atti ML; Salmaso S; Bella A; Arigliani R; Gangemi M; Chiamenti G; Brusoni G; Tozzi AE;
Pediatr Infect Dis J; 2002 Aug; 21(8):763-8. PubMed ID: 12192166
[TBL] [Abstract][Full Text] [Related]
9. Measles outbreak linked to insufficient vaccination coverage in Nouvelle-Aquitaine Region, France, October 2017 to July 2018.
Bernadou A; Astrugue C; Méchain M; Le Galliard V; Verdun-Esquer C; Dupuy F; Dina J; Aït-Belghiti F; Antona D; Vandentorren S
Euro Surveill; 2018 Jul; 23(30):. PubMed ID: 30064543
[TBL] [Abstract][Full Text] [Related]
10. Trend of measles, mumps, and rubella incidence following the measles-rubella catch up vaccination in the Republic of Korea, 2001.
Choe YJ; Eom HE; Cho SI
J Med Virol; 2017 Sep; 89(9):1528-1531. PubMed ID: 28303592
[TBL] [Abstract][Full Text] [Related]
11. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
[TBL] [Abstract][Full Text] [Related]
12. MMR vaccination and disease elimination: the Finnish experience.
Davidkin I; Kontio M; Paunio M; Peltola H
Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347
[TBL] [Abstract][Full Text] [Related]
13. Ongoing measles outbreak in Romania, 2011.
Stanescu A; Janta D; Lupulescu E; Necula G; Lazar M; Molnar G; Pistol A
Euro Surveill; 2011 Aug; 16(31):. PubMed ID: 21871218
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study.
Mossong J; Putz L; Schneider F
Epidemiol Infect; 2004 Jan; 132(1):11-8. PubMed ID: 14979584
[TBL] [Abstract][Full Text] [Related]
15. Determinants of students' willingness to accept a measles-mumps-rubella booster vaccination during a mumps outbreak: a cross-sectional study.
Donkers HW; Hautvast JL; Akkermans RP; Swaan CM; Ruijs WL; Hulscher ME
BMC Public Health; 2015 Jun; 15():575. PubMed ID: 26092263
[TBL] [Abstract][Full Text] [Related]
16. Effect of the mandatory vaccination law on measles and rubella incidence and vaccination coverage in Italy (2013-2019).
Sindoni A; Baccolini V; Adamo G; Massimi A; Migliara G; De Vito C; Marzuillo C; Villari P
Hum Vaccin Immunother; 2022 Dec; 18(1):1950505. PubMed ID: 34346840
[TBL] [Abstract][Full Text] [Related]
17. Measles Outbreak in a Highly Vaccinated Population - Israel, July-August 2017.
Avramovich E; Indenbaum V; Haber M; Amitai Z; Tsifanski E; Farjun S; Sarig A; Bracha A; Castillo K; Markovich MP; Galor I
MMWR Morb Mortal Wkly Rep; 2018 Oct; 67(42):1186-1188. PubMed ID: 30359348
[TBL] [Abstract][Full Text] [Related]
18. Ongoing measles and rubella transmission in Georgia, 2004-05: implications for the national and regional elimination efforts.
Doshi S; Khetsuriani N; Zakhashvili K; Baidoshvili L; Imnadze P; Uzicanin A
Int J Epidemiol; 2009 Feb; 38(1):182-91. PubMed ID: 19074954
[TBL] [Abstract][Full Text] [Related]
19. Measles, Mumps, and Rubella Serostatus and Response to MMR Vaccination Among HIV-Infected Adults.
Singh HK; Chiu YL; Wilkin T
AIDS Patient Care STDS; 2015 Sep; 29(9):461-4. PubMed ID: 26153909
[No Abstract] [Full Text] [Related]
20. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
Matter L; Germann D; Bally F; Schopfer K
Eur J Epidemiol; 1997 Jan; 13(1):61-6. PubMed ID: 9062781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
